Haiqing Ma
About
In The Last Decade
Haiqing Ma
27 papers receiving 961 citations
Peers
Comparison fields: 5 of 81
- Molecular Biology 511
- Oncology 425
- Cancer Research 321
- Pulmonary and Respiratory Medicine 211
- Epidemiology 155
Countries citing papers authored by Haiqing Ma
This map shows the geographic impact of Haiqing Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiqing Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiqing Ma more than expected).
Fields of papers citing papers by Haiqing Ma
This network shows the impact of papers produced by Haiqing Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiqing Ma. The network helps show where Haiqing Ma may publish in the future.
Co-authorship network of co-authors of Haiqing Ma
This figure shows the co-authorship network connecting the top 25 collaborators of Haiqing Ma. A scholar is included among the top collaborators of Haiqing Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haiqing Ma. Haiqing Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 1 | |
| 3 | 34 | |
| 4 | 1 | |
| 5 | 17 | |
| 6 | Trends in incidence and survival in patients with melanoma, 1974-2013. | 31 |
| 7 | 8 | |
| 8 | 12 | |
| 9 | 15 | |
| 10 | 141 | |
| 11 | 42 | |
| 12 | 47 | |
| 13 | 3 | |
| 14 | 22 | |
| 15 | 102 | |
| 16 | 22 | |
| 17 | 34 | |
| 18 | 23 | |
| 19 | 1 | |
| 20 | Expression of ERCC1, Bcl-2, MT and their clinical significance in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.